Leading CDMO Samsung Biologics Receives ESG Award in 2022
After making a concerted effort in 2021 to address environmental concerns, leading CDMO Samsung Biologics gained recognition in its industry and in South Korea for its emphasis on ESG. The company recognized that ESG, or the focus on environmental, social, and governance aspects of running a business, would be an investment in the future of…